Primary purpose: To evaluate the effectiveness of deuterated tetrabenazine in the real-world treatment of adult patients with chorea associated with Huntington's disease in China.
Secondary objective: To evaluate the safety of deuterated tetrabenazine in real-world Chinese adult patients with chorea associated with Huntington's disease.
[Translation] A Chinese real-world study on the effectiveness and safety of Antita (deuterated tetrabenazine) in the treatment of adults with tardive dyskinesia
评估安泰坦(氘丁苯那嗪)治疗中国成人迟发性运动障碍患者的安全性数据
[Translation]
Evaluating the safety data of Antitan (deuterated tetrabenazine) in the treatment of Chinese adults with tardive dyskinesia
[Translation] An open-label, single-dose study to evaluate the pharmacokinetics of deuterated tetrabenazine and its active metabolite in healthy Chinese subjects after a single dose of 12 mg Antitan® tablets
Evaluation of TEV-50717 (parent drug) and its active deuterated metabolite α-dihydrotetrabenazine (α-HTBZ) and Pharmacokinetic characteristics of β-dihydrotetrabenazine (β-HTBZ) (sum and individual components).
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.